What is Generate Biomedicines, Inc. 's net income?

Generate Biomedicines, Inc. (GENB) reported net income of -$61.45M in Q1 2026.

What does net income mean?

The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.

Generate Biomedicines, Inc. GENB Net Income

Net Income at other companies

MYR GroupMYRG

$46.8M+101%

Axis Capital HoldersAXS

$254.77M+31.3%

Stag IndustrialSTAG

$62M-32.2%

Scholar RockSRRK

-$105.51M-41.2%

Constellation EnergyCEG

$1.59B+1,247%

BOB

Bob's Discount Furniture BOBS

$2.52M-80.9%

Other financials

Income statement

See full

Revenue$7.2M-18.1%

Operating income-$64.1M-33.1%

EPS (diluted)-$1.07+34.0%

Balance sheet

See full

Cash & equivalents$160.6M-27.2%

Total debt$65.6M—

Total equity$514.8M+209%

Total assets$625.7M—

Cash flow

See full

Operating cash flow-$80.4M-51.2%

CapEx$3.8M+403%

Free cash flow-$84.2M-56.1%

Valuation

See full

Market cap$1.86B—

Enterprise value$1.76B—

Returns & leverage

See full

Debt / equity0.1×—

Current ratio9.2×—

Where this comes from

Reported directly by Generate Biomedicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLoss.

The official record: Generate Biomedicines, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Generate Biomedicines, Inc. 's net income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Generate Biomedicines, Inc. 's net income?: Generate Biomedicines, Inc. (GENB) reported net income of -$61.45M in Q1 2026.
What does net income mean?: The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.